Prime editing allows precise changes to be made to DNA. A new way of editing the code of life could correct 89% of the errors in DNA that cause disease, say US scientists. The technology ...

Achieving the aggregation of different mutation types at multiple genomic loci and generating transgene-free plants in the T0 ...

Silvan Tuerkcan, an analyst from JMP Securities, has initiated a new Buy rating on Prime Medicine, Inc. (PRME).Pick the best stocks and ...

Cas9-mediated tools are the foundation of CRISPR technologies, setting the stage for new generation base editors and prime editors, and opening the door to genome editing therapeutics with greater ...

to initiate trials of the first-ever prime editing drug. The FDA cleared Prime Medicine’s investigational new drug (IND) application for PM359 for the treatment of chronic granulomatous disease ...

Prime Medicine has been given the go-ahead by the FDA for the first human trial of its prime editing technology, which promises to deliver one-shot therapies for a range of severe genetic diseases.